GALVmed has received funding approval totalling to US$ 19 million for the Phase 3 programme on Improved Tools for the Control of Animal African Trypanosomosis (Tryps 3). The main objective […]

Arusha, 1st October 2018 – The first licences for a veterinary vaccine submitted for registration under the East African Community’s Mutual Recognition Procedure (MRP) have been issued. Obtaining approval to […]

GALVmed representatives Jeremy Salt and Mark Rweyemamu are this week attending a meeting in Vienna, Austria, to launch the Peste des petits ruminants Global Research and Expertise Network (PPR-GREN). The […]

After more than 5 years leading GALVmed, and having recently received our latest round of funding, the time has come to consider my retirement. At our recent Board meeting in […]

Jeremy Salt, our Chief Scientific Officer attended two meetings highlighted in this March edition of  STAR-IDAZ. Jeremy is a member of the scientific committee of International Research Consortium on Animal […]

EDINBURGH, UK, February 21, 2018 – As the global US $30m Brucellosis Vaccine Prize competition enters its second phase, organisers are calling on commercial and academic organisations to join forces […]

26 January, 2018, Edinburgh, U.K.: Bill Gates, co-chair of the Bill & Melinda Gates Foundation, will today visit the University of Edinburgh with the Secretary of State for International Development […]